EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nanomedicine Combats Drug Resistance in Lung Cancer

Xiuli Zheng iD, Xiaohai Song iD, Guonian Zhu, Dayi Pan, Haonan Li, Jiankun Hu, Kai Xiao, Qiyong Gong iD, Zhongwei Gu iD, Kui Luo iD, Weimin Li iD

Advanced Materials · 2024-01 · 36 (3)

DOI: 10.1002/adma.202308977 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Materials, online erschienen am 27.11.2023. Verfasst von Xiuli Zheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Department of Respiratory, Huaxi MR Research Center (HMRRC) and Critical Care Medicine, Institute of Respiratory Health, Pre…. Hauptthemen laut MEDLINE: Lung Neoplasms, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 550 Literaturangaben. Gefördert von: 1·3·5 project for disciplines of excellence, West China Hospital, Sichuan University, National Natural Science Foundation of China, National Postdoctoral Program for Innovative Talents.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer is the second most prevalent cancer and the leading cause of cancer‐related death worldwide. Surgery, chemotherapy, molecular targeted therapy, immunotherapy, and radiotherapy are currently available as treatment methods. However, drug resistance is a significant factor in the failure of lung cancer treatments. Novel therapeutics have been exploited to address complicated resistance mechanisms of lung cancer and the advancement of nanomedicine is extremely promising in terms of overcoming drug resistance. Nanomedicine equipped with multifunctional and tunable physiochemical properties in alignment with tumor genetic profiles can achieve precise, safe, and effective treatment while minimizing or eradicating drug resistance in cancer. Here, this work reviews the discovered resistance mechanisms for lung cancer chemotherapy, molecular targeted therapy, immunotherapy, and radiotherapy, and outlines novel strategies for the development of nanomedicine against drug resistance. This work focuses on engineering design, customized delivery, current challenges, and clinical translation of nanomedicine in the application of resistant lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsAntineoplastic AgentsNeoplasmsHumansNanomedicineDrug Delivery SystemsDrug Resistance, Neoplasm

Stichwörter der Autor:innen

chemotherapydrug resistanceimmunotherapylung cancermolecular targeted therapynanomedicineradiotherapy

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Radiology, Department of Respiratory, Huaxi MR Research Center (HMRRC) and Critical Care Medicine, Institute of Respiratory Health, Precision Medicine Center, Frontiers Science Center for Disease-Related M…
  • Department of General Surgery, Gastric Cancer Center and Laboratory of Gastric Cancer, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu, 610041, China.
  • Precision Medicine Key Laboratory of Sichuan Province, Functional and Molecular Imaging Key Laboratory of Sichuan Province, and Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Chengdu, 610041, Chi…
  • Department of Radiology, West China Xiamen Hospital of Sichuan University, Xiamen, Fujian, 361000, China.

ORCID-Profile: Xiuli Zheng, Xiaohai Song, Qiyong Gong, Zhongwei Gu, Kui Luo, Weimin Li

Förderung

  • 1·3·5 project for disciplines of excellence, West China Hospital, Sichuan University
  • National Natural Science Foundation of China
  • National Postdoctoral Program for Innovative Talents

Zitieren

APA

Zheng, X., Song, X., Zhu, G., Pan, D., Li, H., Hu, J., Xiao, K., Gong, Q., Gu, Z., Luo, K., & Li, W. (2024). Nanomedicine Combats Drug Resistance in Lung Cancer. Advanced Materials, 36(3). https://doi.org/10.1002/adma.202308977

Vancouver

Zheng X, Song X, Zhu G, Pan D, Li H, Hu J, et al. Nanomedicine Combats Drug Resistance in Lung Cancer. Advanced Materials. 2024;36(3). doi:10.1002/adma.202308977

BibTeX
@article{Zheng2024,
  author = {Zheng, Xiuli and Song, Xiaohai and Zhu, Guonian and Pan, Dayi and Li, Haonan and Hu, Jiankun and Xiao, Kai and Gong, Qiyong and Gu, Zhongwei and Luo, Kui and Li, Weimin},
  title = {Nanomedicine Combats Drug Resistance in Lung Cancer},
  journal = {Advanced Materials},
  year = {2024},
  volume = {36},
  number = {3},
  doi = {10.1002/adma.202308977}
}
Kostenlos starten →